Related Experiment Video
Updated: Jul 13, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Refuting the net risks test: a response to Wendler and Miller's "Assessing research risks systematically"
1Department of Philosophy, Talbot College, University of Western Ontario, London, Ontario, Canada, N6A 3K7. charles.weijer@dal.ca
Abstract:
Earlier in the pages of this journal (p 481), Wendler and Miller offered the "net risks test" as an alternative approach to the ethical analysis of benefits and harms in research. They have been vocal critics of the dominant view of benefit-harm analysis in research ethics, which encompasses core concepts of duty of care, clinical equipoise and component analysis. They had been challenged to come up with a viable alternative to component analysis which meets five criteria. The alternative must (1) protect research subjects; (2) allow clinical research to proceed; (3) explain how physicians may offer trial enrolment to their patients; (4) address the challenges posed by research containing a mixture of interventions and (5) define ethical standards according to which the risks and potential benefits of research may be consistently evaluated. This response argues that the net risks test meets none of these criteria and concludes that it is not a viable alternative to component analysis.
Insights
The net risks test fails to meet essential ethical criteria for research. This analysis demonstrates it does not protect subjects or adequately evaluate research risks and benefits.
Area of Science:
- Medical Ethics
- Clinical Research Ethics
Background:
- The "net risks test" was proposed as an alternative to traditional benefit-harm analysis in research ethics.
- Critics argue the dominant benefit-harm analysis, including component analysis, is insufficient.
- The net risks test was challenged to meet five specific ethical criteria.
Purpose of the Study:
- To evaluate whether the proposed "net risks test" meets the five criteria for an ethical research analysis.
- To determine if the net risks test is a viable alternative to component analysis in research ethics.
Main Methods:
- Critical analysis of the "net risks test" against established ethical standards for research.
- Evaluation of the net risks test's ability to address specific challenges in clinical research, including mixed interventions and physician-patient communication.
Main Results:
- The net risks test fails to meet any of the five proposed ethical criteria.
- The test does not adequately protect research subjects.
- It does not provide a consistent framework for evaluating research risks and benefits.
Conclusions:
- The "net risks test" is not a viable alternative to component analysis in research ethics.
- The proposed test falls short in protecting participants and guiding ethical research practices.
- Component analysis remains the more robust ethical framework for evaluating research.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Relative Risk
Regression Toward the Mean

